ATRS
Antares Pharma Inc
Price:  
5.59 
USD
Volume:  
1,763,397.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Antares EV/EBITDA

4.9%
Upside

As of 2024-02-26, the EV/EBITDA ratio of Antares Pharma Inc (ATRS) is 13.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Antares's latest enterprise value is 955.06 mil USD. Antares's TTM EBITDA according to its financial statements is 69.78 mil USD. Dividing these 2 quantities gives us the above Antares EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.5x - 13.8x 13.4x
Forward P/E multiples 10.5x - 15.2x 11.5x
Fair Price 4.30 - 8.22 5.86
Upside -23.1% - 47.1% 4.9%
5.59 USD
Stock Price
5.86 USD
Fair Price

Antares EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA